| A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) (NCT05625919) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-11-08 |
| First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients (NCT05601726) | Advanced BioDesign | 2022-11-08 |
| A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects (NCT05559125) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2022-11-08 |
| Study to Assess Safety and Tolerability of Multiple Doses of EO2002 (NCT05636579) | Asociación para Evitar la Ceguera en México | 2022-11-08 |
| A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers (NCT05753878) | Huahui Health | 2022-11-08 |
| A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals. (NCT04882514) | University of Alberta | 2022-11-07 |
| Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 (NCT05504876) | Sunshine Lake Pharma Co., Ltd. | 2022-11-07 |
| A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age (NCT05575492) | ModernaTX, Inc. | 2022-11-07 |
| Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA) (NCT05698017) | Cytora Ltd. | 2022-11-07 |
| Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions. (NCT06124573) | Galenicum Health | 2022-11-07 |
| A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants (NCT05613387) | Zealand Pharma | 2022-11-07 |
| Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies (NCT05573724) | AstraZeneca | 2022-11-07 |
| BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors (NCT06368960) | InnoBM Pharmaceuticals Co., Ltd. | 2022-11-07 |
| A Study of PRA052 in Healthy Volunteers (NCT05603182) | Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2022-11-07 |
| Effects of E-cigarette Flavors on Youth TCORS 2.0 (NCT03634839) | Yale University | 2022-11-07 |
| A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants (NCT05677893) | Oneness Biotech Co., Ltd. | 2022-11-07 |
| A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis (NCT05549323) | Pfizer | 2022-11-07 |
| A Study in Healthy Men to Test Whether BI 474121 Can Reverse the Memory Problems Caused by Ketamine (NCT05451095) | Boehringer Ingelheim | 2022-11-07 |
| Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients (NCT05468359) | St. Jude Children's Research Hospital | 2022-11-07 |
| HB0034 in Patients With Generalized Pustular Psoriasis (GPP) (NCT05512598) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-11-06 |
| NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE) (NCT05354713) | NVP Healthcare | 2022-11-05 |
| A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects. (NCT05630677) | AstraZeneca | 2022-11-04 |
| PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects (NCT05564611) | Kashiv BioSciences, LLC | 2022-11-04 |
| A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects (NCT05560360) | Jiangsu HengRui Medicine Co., Ltd. | 2022-11-04 |
| A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients (NCT05758610) | Shengke Pharmaceuticals (Jiangsu) Limited, China | 2022-11-04 |
| A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors (NCT05614102) | Bayer | 2022-11-04 |
| HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study (NCT05720767) | Hutchmed | 2022-11-04 |
| Enhancing the Natriuretic Peptide System in HFpEF (NCT05279742) | Horng Chen | 2022-11-04 |
| Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia) (NCT06225336) | Auregen Biotherapeutics, SA | 2022-11-04 |
| A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma (NCT05364424) | Hoffmann-La Roche | 2022-11-04 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive (NCT05590338) | GlaxoSmithKline | 2022-11-04 |
| A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis (NCT05807529) | Orient Europharma Co., Ltd. | 2022-11-03 |
| Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies (NCT05011422) | Washington University School of Medicine | 2022-11-03 |
| Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction (NCT06565728) | Cairo University | 2022-11-03 |
| Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers (NCT05604690) | Intravacc B.V. | 2022-11-03 |
| Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell Lymphoma (NCT04639843) | National Cancer Institute (NCI) | 2022-11-03 |
| Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma (NCT05272384) | National Cancer Institute (NCI) | 2022-11-03 |
| Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older (NCT05608005) | Sanofi Pasteur, a Sanofi Company | 2022-11-03 |
| Heat Therapy, Functional Capacity, and Vascular Health in Older Adults (NCT05706181) | University of North Texas Health Science Center | 2022-11-03 |
| A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07) (NCT05524545) | ALX Oncology Inc. | 2022-11-02 |
| Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects (NCT05571813) | Chong Kun Dang Pharmaceutical | 2022-11-02 |
| Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia (NCT05577312) | Bioray Laboratories | 2022-11-02 |
| Study the Effect of Omeprazole on AB-106 Pharmacokinetics (NCT05609929) | Nuvation Bio Inc. | 2022-11-02 |
| A Drug Interaction Study of LY3871801 in Healthy Participants (NCT05602675) | Eli Lilly and Company | 2022-11-02 |
| Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence (NCT05616208) | Cellf Bio LLC | 2022-11-02 |
| Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women (NCT05587283) | AtoGen Co. Ltd | 2022-11-02 |
| A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies (NCT05567887) | Pfizer | 2022-11-02 |
| The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study (NCT06355193) | Central South University | 2022-11-01 |
| Comparison of Co2 Laser Versus Co2 Laser With PRP in Scars (NCT05887232) | Combined Military Hospital Abbottabad | 2022-11-01 |
| Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts (NCT05895071) | Combined Military Hospital Abbottabad | 2022-11-01 |
| Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma (NCT05607420) | Cellectis S.A. | 2022-11-01 |
| Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma (NCT05472220) | Pamela Munster | 2022-11-01 |
| KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) (NCT05603572) | Primocure Pharma | 2022-11-01 |
| A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases (NCT05564221) | Yuhan Corporation | 2022-11-01 |
| Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata (NCT05885269) | Combined Military Hospital Abbottabad | 2022-11-01 |
| Relationship Between Serum Vitamin D and Outcomes of Liver Transplantation in Cirrhotic Patients Undergoing Liver Transplantation and Effects of Vitamin D Supplementation in Post-transplant Period (NCT05568836) | National Nutrition and Food Technology Institute | 2022-11-01 |
| Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block Compared to the Combined Therapy With Spermatic Cord Block (NCT05600296) | Egymedicalpedia | 2022-11-01 |
| Oral Cannabidiol for Tobacco Cessation (NCT05445804) | Johns Hopkins University | 2022-11-01 |
| Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (NCT05506982) | Emory University | 2022-11-01 |
| A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002) (NCT05579132) | MSD R&D (China) Co., Ltd. | 2022-11-01 |
| KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC (NCT05254184) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-11-01 |
| Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer (NCT05747313) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-11-01 |
| Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy (NCT05111860) | Shanghai Minimally Invasive Surgery Center | 2022-11-01 |
| Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma (NCT05887219) | Combined Military Hospital Abbottabad | 2022-11-01 |
| A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma (NCT05607095) | Memorial Sloan Kettering Cancer Center | 2022-11-01 |
| Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients (NCT05577364) | Sun Yat-sen University | 2022-11-01 |
| A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (NCT05473910) | TScan Therapeutics, Inc. | 2022-11-01 |
| Assesment of Two Different Modalities of Maxillary Canine Retraction Assisted With Injectable Platelet Rich Fibrin (NCT05429437) | Al-Azhar University | 2022-11-01 |
| Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine (NCT05586464) | Liaocheng People's Hospital | 2022-11-01 |
| SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors (NCT05525559) | Etern BioPharma (Shanghai) Co., Ltd | 2022-11-01 |
| A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma (NCT05572463) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-11-01 |
| Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas (NCT05557851) | Minneamrita Therapeutics LLC | 2022-11-01 |
| NGF Treatment for Patients With Neuropathic Corneal Pain (NCT05700864) | Tufts Medical Center | 2022-11-01 |
| Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer (NCT04947189) | St Vincent's Hospital, Sydney | 2022-11-01 |
| Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries (NCT05872087) | Ain Shams University | 2022-11-01 |
| Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum (NCT05897112) | Combined Military Hospital Abbottabad | 2022-11-01 |
| Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects (NCT05610202) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-11-01 |
| A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy (NCT06470347) | Zunyi Medical College | 2022-11-01 |
| Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells (NCT05520112) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-11-01 |
| Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma (NCT05700955) | University of Louisville | 2022-11-01 |
| Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma (NCT05884151) | Combined Military Hospital Abbottabad | 2022-11-01 |
| Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer (NCT04701645) | Brigham and Women's Hospital | 2022-11-01 |
| Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A (NCT05500807) | Bleeding and Clotting Disorders Institute Peoria, Illinois | 2022-11-01 |
| DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (NCT04616729) | Universitair Ziekenhuis Brussel | 2022-11-01 |
| Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles (NCT05520125) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2022-11-01 |
| A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS) (NCT03773328) | Cellenkos, Inc. | 2022-11-01 |
| Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects (NCT04080895) | University of Oxford | 2022-11-01 |
| Phase I Clinical Trial of a Candidate PCV13 in Healthy People (NCT05602480) | Wuhan BravoVax Co., Ltd. | 2022-11-01 |
| Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances (NCT05092451) | M.D. Anderson Cancer Center | 2022-11-01 |
| A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Hepatic Impairment Compared With Matched Healthy Participants (NCT05753592) | Novartis Pharmaceuticals | 2022-10-31 |
| CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma (NCT05325281) | Medical College of Wisconsin | 2022-10-31 |
| A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors (NCT05585320) | Immuneering Corporation | 2022-10-31 |
| EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma (NCT04664179) | Baylor College of Medicine | 2022-10-31 |
| Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors (NCT05909436) | Guangzhou Gloria Biosciences Co., Ltd. | 2022-10-31 |
| 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05263284) | City of Hope Medical Center | 2022-10-31 |
| A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function. (NCT05582187) | Basilea Pharmaceutica | 2022-10-31 |
| Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus (NCT05490511) | Indiana University | 2022-10-31 |
| A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation (NCT07231068) | Henan Genuine Biotech Co., Ltd. | 2022-10-31 |
| First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria (NCT05781399) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-10-31 |
| Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects (NCT05473533) | Pieris Australia Pty Ltd | 2022-10-31 |